US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar Oct 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including Amrize, Dexcom, and Lennar, on Thursday.
HIGHLIGHTS
* Amrize AMRZ.N: Barclays initiates coverage with equal-weight rating; PT $55 |
* Dexcom DXCM.O: RBC ups PT to $105 from $90 |
* Lennar LEN.N: Morgan Stanley initiates coverage with underweight rating; PT $65 |
* Levi Strauss & Co LEVI.N: Jefferies cuts PT to $25 from $27 |
* Synopsys SNPS.O: Deutsche Bank ups PT to $640 from $590 |
The following is a summary of research actions on US companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Agree Realty ADC.N: RBC cuts PT to $73 from $82 |
* AIG AIG.N: BofA Global Research cuts price objective to $88 from $92 |
* Albemarle ALB.N: Mizuho cuts PT to $130 from $140 |
* Allstate Corp ALL.N: BofA Global Research raises price objective to $336 from $334 |
* American Airlines AAL.O: Jefferies cuts target price to $12 from $15 |
* Amrize AMRZ.N: Barclays initiates coverage with equal-weight rating; PT $55 |
* Amrize AMRZ.N: Citigroup cuts target price to $50 from $58 |
* Apple AAPL.O: Morgan Stanley cuts target price to $355 from $360 |
* Atmos Energy ATO.N: Jefferies cuts PT to $167 from $173 |
* Atossa Therapeutics ATOS.O: Ascendiant Capital Markets ups PT to $25 from $24 |
* Axogen AXGN.O: Truist Securities cuts target price to $53 from $60 |
* Banc of California BANC.N: Piper Sandler cuts PT to $22 from $23 |
* Bank of America BAC.N: Truist Securities cuts target price to $62 from $65 |
* Bank of Hawaii BOH.N: Piper Sandler cuts PT to $78 from $85 |
* Bank of Marin Bancorp BMRC.O: Piper Sandler cuts PT to $29 from $30 |
* Banner Corp BANR.O: Piper Sandler cuts PT to $71 from $74 |
* BJ's Restaurants BJRI.O: Mizuho raises target price to $76 from $74 |
* BJ's Restaurants BJRI.O: Mizuho raises to outperform from neutral |
* Blackstone BX.N: HSBC cuts PT to $122 from $135 |
* Blackstone Digital Infrastructure Trust BXDC.N: Moffettnathanson cuts PT to $20 from $21 |
* Brown & Brown BRO.N: JP Morgan ups PT to $83 from $80 |
* Cal-Maine Foods CALM.O: Stephens cuts target price to $70 from $80 |
* Carmax KMX.N: Barclays raises target price to $67 from $61 |
* Carmax KMX.N: Stephens ups PT to $81 from $74 |
* Carnival Corporation CCL.N: Citigroup cuts target price to $35 from $37 |
* Cigna CI.N: Jefferies cuts PT to $288 from $307 |
* Cincinnati Financial Corporation CINF.O: BofA Global Research cuts price objective to $187 from $193 |
* City Holding Co CHCO.O: KBW ups PT to $145 from $135 |
* Civeo CVEO.N: Northland Capital initiates coverage with outperform rating; PT $42 |
* Clorox CLX.N: TD Cowen cuts PT to $85 from $90 |
* Compass Group CPG.L: Deutsche Bank cuts PT to $35 from $40 |
* Conagra Brands CAG.N: Bernstein cuts target price to $11 from $12 |
* Conagra Brands CAG.N: TD Cowen cuts target price to $13 from $14 |
* Connect Biopharma Holdings Ltd CNTB.O: BTIG cuts PT to $5 from $10 |
* CRH Plc CRH.N: Citigroup cuts target price to $106 from $122 |
* Customers Bancorp CUBI.N: JP Morgan cuts PT to $92 from $96 |
* D.R. Horton DHI.N: Morgan Stanley initiates coverage with equal weight rating |
* D.R. Horton DHI.N: Morgan Stanley initiates coverage with target price $151 |
* Delta Air Lines DAL.N: Jefferies cuts target price to $95 from $110 |
* Dexcom DXCM.O: RBC ups PT to $105 from $90 |
* Dick's Sporting Goods DKS.N: Truist Securities cuts PT to $128 from $135 |
* Digital Turbine APPS.O: RBC initiates coverage with outperform rating; PT $15 |
* Dow DOW.N: Mizuho cuts PT to $32 from $35 |
* Draftkings DKNG.O: BTIG cuts target price to $25 from $30 |
* Dynatrace DT.N: UBS raises target price to $74 from $65 |
* E.L.F. Beauty ELF.N: Raymond James raises PT to $117 from $100 |
* Eagle Materials Inc EXP.N: Citigroup cuts target price to $190 from $232 |
* Eastman Chemical Co EMN.N: Mizuho cuts PT to $80 from $85 |
* Element Solutions ESI.N: Mizuho cuts PT to $42 from $45 |
* Enliven Therapeutics ELVN.O: JP Morgan starts coverage with overweight rating; PT $75 |
* EOG Resources EOG.N: JP Morgan raises target price to $164 from $151 |
* Ethos Technologies LIFE.O: JP Morgan cuts to neutral from overweight |
* Euronet Worldwide EEFT.O: Northland Capital cuts target price to $85 from $90 |
* Expeditors International of Washington EXPD.N: Baird ups PT to $200 from $190 |
* Factset FDS.N: BMO raises target price to $300 from $282 |
* Factset FDS.N: Deutsche Bank raises target price to $301 from $299 |
* Factset FDS.N: Stifel raises target price to $292 from $254 |
* First Business Financial Services FBIZ.O: Raymond James assumes coverage with outperform rating |
* First Business Financial Services FBIZ.O: Raymond James assumes coverage with PT $75 |
* First Citizens Bancshares FCNCA.O: JP Morgan cuts PT to $2300 from $2450 |
* First Hawaiian FHB.O: JP Morgan cuts PT to $29 from $30 |
* First Hawaiian FHB.O: JP Morgan raises to neutral from underweight |
* First Hawaiian FHB.O: Piper Sandler cuts PT to $27 from $30 |
* Flagstar Bank Na FLG.N: JP Morgan cuts PT to $14 from $15.50 |
* Flutter Entertainment Plc FLUT.N: BTIG cuts PT to $110 from $113 |
* Forbright FRBT.O: JP Morgan cuts PT to $22 from $23 |
* Forbright FRBT.O: JP Morgan raises to overweight from neutral |
* Freshpet FRPT.O: Needham initiates coverage with hold rating |
* Gaming and Leisure Properties GLPI.O: RBC cuts PT to $44 from $52 |
* Getty Realty GTY.N: RBC cuts PT to $30 from $36 |
* Globus Medical GMED.N: RBC cuts PT to $85 from $115 |
* Goosehead Insurance GSHD.O: JP Morgan cuts PT to $60 from $68 |
* Harmony Biosciences HRMY.O: Deutsche Bank ups PT to $42 from $39 |
* Hewlett Packard Enterprise HPE.N: Barclays ups PT to $83 from $79 |
* Hewlett Packard Enterprise HPE.N: Citigroup raises PT to $92 from $76 |
* Hewlett Packard Enterprise HPE.N: Morgan Stanley ups PT to $72 from $67 |
* Hewlett Packard Enterprise HPE.N: Piper Sandler ups PT to $70 from $57 |
* Hewlett Packard Enterprise HPE.N: Truist Securities ups PT to $75 from $70 |
* Hewlett Packard Enterprise Company HPE.N: UBS raises PT to $66 from $59 |
* Hillman Solutions HLMN.O: Canaccord Genuity cuts PT to $13 from $14 |
* Hub Group HUBG.O: Stifel raises to hold from sell |
* Immunome IMNM.O: Stifel initiates coverage with hold rating; PT $24 |
* Inspire Medical Systems INSP.N: RBC ups PT to $75 from $60 |
* Italy'S Prysmian PRY.MI: Kepler Cheuvreux ups PT to EUR 155 from EUR 151 |
* Jabil JBL.N: Barclays cuts target price to $378 from $426 |
* Jabil JBL.N: JP Morgan ups PT to $430 from $425 |
* KB Home KBH.N: Morgan Stanley starts coverage with underweight rating; PT $39 |
* KKR & Co KKR.N: HSBC cuts PT to $115 from $121 |
* Kratos Defense & Security Solutions KTOS.O: Jefferies cuts PT to $68 from $80 |
* Kura Oncology KURA.O: JP Morgan starts coverage with overweight rating; PT $30 |
* Lam Research LRCX.O: B. Riley raises target price to $390 from $350 |
* Lennar LEN.N: Morgan Stanley initiates coverage with underweight rating; PT $65 |
* Levi Strauss & Co LEVI.N: Jefferies cuts PT to $25 from $27 |
* Levi Strauss & Co LEVI.N: Stifel cuts target price to $27 from $28 |
* Liquidia LQDA.O: BTIG cuts to neutral from buy |
* Liquidia LQDA.O: Jefferies cuts PT to $45 from $115 |
* Liquidia LQDA.O: Needham cuts PT to $72 from $110 |
* Liquidia LQDA.O: Raymond James cuts target price to $53 from $106 |
* Liquidia LQDA.O: Raymond James cuts to outperform from strong buy |
* Marsh & Mclennan Companies MRSH.N: JP Morgan ups PT to $215 from $212 |
* Martin Marietta Materials MLM.N: Citigroup cuts PT to $610 from $690 |
* Merck & Co MRK.N: Jefferies ups PT to $177 from $175 |
* Micron Technology MU.O: D.A. Davidson ups PT to $2100 from $2000 |
* Micron Technology MU.O: Mizuho raises target price to $1400 from $1300 |
* Micron Technology MU.O: Rosenblatt Securities ups PT to $1900 from $1500 |
* Monte Rosa Therapeutics GLUE.O: H.C. Wainwright initiates coverage with PT $25 |
* Monte Rosa Therapeutics GLUE.O: H.C. Wainwright initiates coverage with buy rating |
* National Bank Holdings Corp NBHC.N: Piper Sandler cuts PT to $49 from $51 |
* National Energy Services Reunited NESR.O: BMO initiates coverage with outperform rating |
* National Energy Services Reunited NESR.O: BMO initiates coverage with PT $39 |
* NNN REIT NNN.N: RBC cuts PT to $42 from $47 |
* NVR NVR.N: Morgan Stanley initiates coverage with underweight rating; PT $5058 |
* Old National Bancorp ONB.O: JP Morgan cuts PT to $30 from $32 |
* Orchestra Biomed Holdings OBIO.O: Piper Sandler ups PT to $12 from $10 |
* Ormat Technologies ORA.N: UBS cuts target price to $100 from $157 |
* Ormat Technologies ORA.N: UBS cuts to neutral from buy |
* PBF Energy PBF.N: JP Morgan raises target price to $89 from $83 |
* Pepsico PEP.O: Barclays cuts target price to $133 from $142 |
* Pinnacle Financial Partners PNFP.N: JP Morgan cuts PT to $115 from $120 |
* Pinnacle West Capital PNW.N: Barclays cuts PT to $94 from $108 |
* PNC Financial Services PNC.N: Truist Securities cuts PT to $252 from $264 |
* preferred Bank PFBC.O: Piper Sandler ups PT to $120 from $115 |
* Pultegroup PHM.N: Morgan Stanley initiates coverage with equal weight rating |
* Pultegroup PHM.N: Morgan Stanley initiates coverage with PT $128 |
* Qnity Electronics Q.N: Mizuho cuts PT to $160 from $180 |
* Realty Income O.N: RBC cuts PT to $60 from $70 |
* Regeneron Pharmaceuticals REGN.O: Argus Research raises to buy from hold |
* Rogers ROG.N: B. Riley raises target price to $225 from $200 |
* Sable Offshore SOC.N: Roth MKM cuts PT to $10 |
* Sagimet Biosciences SGMT.O: Oppenheimer raises target price to $38 from $33 |
* Sagimet Biosciences SGMT.O: Oppenheimer ups PT to $38 from $33 |
* Semtech SMTC.O: Oppenheimer raises target price to $225 from $200 |
* Semtech SMTC.O: Oppenheimer ups PT to $225 from $200 |
* Sintx Technologies SINT.O: Ascendiant Capital Markets ups PT to $12.50 from $12 |
* Solstice Advanced Materials SOLS.O: Mizuho cuts PT to $65 from $70 |
* Southstate Bank Corp SSB.N: JP Morgan cuts PT to $120 from $125 |
* Southwest Airlines Co LUV.N: Jefferies cuts target price to $41 from $46 |
* Spyre Therapeutics SYRE.O: Jefferies ups PT to $129 from $126 |
* Spyre Therapeutics SYRE.O: Jonestrading raises target price to $130 from $121 |
* Summit Therapeutics SMMT.O: Barclays raises PT to $20 from $18 |
* Synopsys SNPS.O: Deutsche Bank raises target price to $640 from $590 |
* Synopsys SNPS.O: Deutsche Bank ups PT to $640 from $590 |
* Synopsys SNPS.O: Rosenblatt Securities raises target price to $620 from $575 |
* Texas Capital Bancshares TCBI.O: JP Morgan cuts PT to $100 from $110 |
* the Baldwin Insurance Group BWIN.O: JP Morgan cuts to neutral from overweight |
* the Baldwin Insurance Group BWIN.O: JP Morgan ups PT to $32 from $30 |
* the Progressive Corporation PGR.N: BofA Global Research raises price objective to $314 from $302 |
* The Vita Coco Company COCO.O: Oppenheimer initiates coverage with PT $70 |
* The Vita Coco Company COCO.O: Oppenheimer initiates coverage with outperform rating |
* The Williams Companies WMB.N: Barclays reinstates coverage with overweight rating |
* The Williams Companies WMB.N: Barclays reinstates coverage with PT $82 |
* Titan America SA TTAM.N: Citigroup cuts target price to $18 from $21 |
* Toll Brothers TOL.N: Morgan Stanley starts coverage with overweight rating; PT $159 |
* Travelers TRV.N: BofA Global Research cuts price objective to $301 from $307 |
* Trico Bancshares TCBK.O: Piper Sandler cuts PT to $56.5 from $63 |
* TWFG TWFG.O: JP Morgan cuts PT to $26 from $28 |
* U.S. Bancorp USB.N: Truist Securities cuts target price to $67 from $69 |
* UMB Financial UMBF.O: JP Morgan cuts PT to $160 from $180 |
* United Airlines UAL.O: Jefferies cuts target price to $134 from $155 |
* United Therapeutics UTHR.O: BTIG raises to buy from neutral |
* Valley National Bancorp VLY.O: JP Morgan cuts PT to $15.50 from $17 |
* Valvoline VVV.N: Citigroup cuts target price to $34 from $41 |
* VICI Properties VICI.N: RBC cuts PT to $26 from $29 |
* Vicor VICR.O: Needham raises target price to $350 from $320 |
* Vulcan Materials Co VMC.N: Citigroup cuts target price to $300 from $350 |
* W. R. Berkley Corporation WRB.N: BofA Global Research cuts price objective to $66 from $68 |
* W.P. Carey WPC.N: RBC cuts PT to $67 from $77 |
* Wafd WAFD.O: Piper Sandler cuts PT to $32 from $36 |
* Warner Music Group WMG.O: UBS raises target price to $43 from $42 |
* Wells Fargo WFC.N: Truist Securities raises target price to $95 from $94 |
* Western Alliance Ban WAL.N: JP Morgan cuts PT to $90 from $93 |
* Westlake Corp WLK.N: Mizuho cuts PT to $72 from $88 |
* Westlake Corp WLK.N: Truist Securities cuts target price to $90 from $104 |
* Whitehawk Therapeutics WHWK.O: Stifel initiates coverage with buy rating; PT $9 |
* Zenas Biopharma ZBIO.O: Citigroup raises target price to $48 from $41 |
* Zions Bancorp National Association ZION.O: JP Morgan cuts PT to $65 from $75 |
* Zions Bancorp National Association ZION.O: Piper Sandler cuts PT to $68 from $71 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on DexCom
See all newsHealth Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin
Brief: Dexcom Study Redefines Diabetes Care for Non-Insulin Type 2 Patients
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Dexcom U Enters Season 5 With A Record Roster And Evidence That Diabetes Stigma Among Young Athletes Is Fading
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar